Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 4 II, 1995, Pages

  Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CD4 ANTIGEN; CD8 ANTIGEN; FORMALDEHYDE; INACTIVATED VIRUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS HEMAGGLUTININ;

BRONCHIOLITIS; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0029074792     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/152.4_pt_2.s63     Document Type: Conference Paper

References (48)

1. Chin J., R. L. Magoffin, L. A. Shearer, et al. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
2. Fulginiti, V. A., J. J. Eller, O. F. Sieber, et al. 1969. Respiratory virus immunization, I: a field trial of two inactivated respiratory virus vaccines an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
3. Kim, H. W., G. J. Canchola, C. D. Brandt, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
4. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, et al. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
5. Wright, P. F., T. Shinozaki, W. Fleet, et al. 1976. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J. Pediatr. 88:931-936.
6. Kim, H. W., J. O. Arrobio, C. D. Brandt, et al. 1973. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Pediatr. 52:56-63.
7. Wright, P. F., R. B. Belshe, H. W. Kim, et al. 1982. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect. Immunity 37:397-400.
8. Friedewald, W. T., B. R. Forsyth, C. B. Smith, et al. 1968. Low-temperature-grown RS virus in adult volunteers. J.A.M.A. 203:690-694.
9. Kim, H. W., J. O. Arrobio, G. Pyles, et al. 1971. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatr. 48:745-755.
10. Belshe, R. B., L. P. Van Voris, and M. A. Mufson. 1982. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 145:311-319.
11. Fulginiti, V. A., J. J. Eller, A. W. Downie, et al. 1967. Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccine. J.A.M.A. 202:1075-1080.
12. Nader, P. R., M. S. Horwitz, and J. Rosseau. 1968. Atypical exanthem following exposure to natural measles: eleven cases in children previously inoculated with killed vaccine. J. Pediatr. 72:22-28.
13. Rauh, L. W., and R. Schmidt. 1965. Measles immunization with killed virus vaccine. Am. J. Dis. Child. 109:232-237.
14. Karzon, D. T., D. Rush, and W. Winkelstein. 1965. Immunization with inactivated measles virus vaccine: effect of booster dose and response to natural challenge. Pediatr. 36:40-50.
15. Groothuis, J. R., E. A. Simoes, M. J. Levin, et al. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children: the Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 329:1524-1530.
16. Prince, G. A., V. G. Hemming, R. L. Horswood, et al. 1985. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Vir. Res. 3:193-206.
17. Taylor, G., E. J. Stott, M. Bew, et al. 1983. Monoclonal antibodies protect against respiratory syncytial virus. Lancet 2:976. (Letter)
18. Walsh, E. E., J. J. Schlesinger, and M. W. Brandriss. 1984. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immunity 43:756-758.
19. Gruber, W. C., S. Z. Wilson, B. J. Throop, et al. 1987. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr. Res. 21:270-274.
20. Graham, B. S., T. H. Davis, Y. W. Tang, et al. 1993. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatr. Res. 34: 167-172.
21. Murphy, B. R., G. A. Prince, E. E. Walsh, et al. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 24:197-202.
22. Murphy, B. R., and E. E. Walsh. 1988. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J. Clin. Microbiol. 26:1595-1597.
23. Panuska, J. R., N. M. Cirino, F. Midulla, et al. 1990. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J. Clin. Invest. 86:113-119.
24. Krilov, L. R., L. J. Anderson, L. Marcoux, et al. 1989. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J. Infect. Dis. 160:777-782.
25. Isaacs, D., C. R. Bangham, and A. J. McMichael. 1987. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 2:769-771.
26. Cherrie, A. H., K. Anderson, G. W. Wertz, et al. 1992. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J. Virol. 66:2102-2110.
27. Cannon, M. J., E. J. Stott, G. Taylor, et al. 1987. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunol. 62:133-138.
28. Cannon, M. J., P. J. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
29. Muñoz, J. L., C. A. McCarthy, M. E. Clark, et al. 1991. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J. Virol. 65:4494-4497.
30. Graham, B. S., L. A. Bunton, P. F. Wright, et al. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88: 1026-1033.
31. Tang, Y. W., and B. S. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94:1953-1958.
32. Connors, M., A. B. Kulkarni, C. Y. Firestone, et al. 1992. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66:7444-7451.
33. Kim, H. W., S. L. Leikin, J. Arrobio, et al. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:75-78.
34. Harris, R. W., P. Isacson, and D. T. Karzon. 1969. Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine. J. Pediatr. 74:552-563.
35. Fulginiti, V. A., and J. H. Arthur. 1969. Altered reactivity to measles virus: skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine. J. Pediatr. 75:609-616.
36. Graham, B. S., G. S. Henderson, Y. W. Tang, et al. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
37. Alwan, W. H., W. J. Kozlowska, and P. J. M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
38. Openshaw, P. J., S. L. Clarke, and F. M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4: 493-500.
39. Ward, B. J., and D. E. Griffin. 1993. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 67:171-177.
40. Scott, P., R. Natovitz, R. L. Coffman, et al. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
41. Gazzinelli, R. T., F. T. Hakim, S. Hieny, et al. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292.
42. Sher, A., R. L. Coffman, S. Hieny, et al. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:3911-3916.
43. Pearce, E. J., P. Caspar, J. M. Grzych, et al. 1991. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173: 159-166.
44. Romani, L. S., S. Mocci, C. Bietta, et al. 1991. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immunity 59:4647-4654.
45. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171-177.
46. Yamamura, M., K. Uyemura, R. J. Deans, et al. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.
47. Peltz, G. 1991. A role for CD4+ T cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol. Rev. 123:23-35.
48. Del Prete, G. F., M. De Carli, C. Mastromauro, et al. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite T (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.